Palonosetron
Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.
Year introduced: 2019 (1993)
PubMed search builder options
Subheadings:
Tree Number(s): D03.605.687.319, D03.633.100.531.629
MeSH Unique ID: D000077924
Registry Number: 5D06587D6R
Entry Terms:
- 2-QHBIQO
- RS 25233-198
- RS 25233198
- RS 25233 198
- RS-25233-198
- RS25233198
- RS 25259-197
- RS 25259197
- RS 25259 197
- RS-25259-197
- RS25259197
- RS 25259-198
- RS 25259198
- RS 25259 198
- RS-25259-198
- RS25259198
- Palonosetron, (S-(R*,S*))-isomer
- Palonosetron, (R-(R*,R*))-isomer
- Palonosetron, (3R)-
- Palonosetron, (R-(R*,S*))-isomer
- RS 25259
- RS-25259
- RS25259
- Palonosetron Hydrochloride
- Aloxi
- RS 25233-197
- RS 25233197
- RS 25233 197
- RS-25233-197
- RS25233197
- 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one
Pharmacologic Action: